Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics

NCT ID: NCT01036243

Last Updated: 2012-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

480 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-12-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate that infants have improved gut comfort when fed a slightly hydrolyzed starter formula containing probiotics compared to infants fed a control hydrolyzed and referenced non-hydrolyzed formula.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Infants often experience undesirable gastrointestinal effects, such as constipation, flatulence. These symptoms are often perceived by the parents as being related to the diet (formula) the baby is consuming. In another hand, infantile colic or fussing/crying is one of the most commonly encountered problems within the first three months of life. The etiology of the disorder remains unknown however, three main theories have been proposed to explain its origin: (i) psychological: due to inadequate mother-infant interaction (ii) gastrointestinal: such as hypertonicity and immaturity of the GI tract and Dietary factors that may influence the stool pattern in formula fed infants are (iii) allergic: due to a reaction against cow's milk protein or other food constituents. e.g. the protein source, the iron content, hydrolyzation of the protein, or the fat source.

It has been reported that infants receiving a casein predominant formula had less unformed stools than those receiving a whey predominant formula. Hydrolysation of protein resulted in reduced gastro-intestinal transit time and some studies using extensively hydrolyzed protein formula have shown more liquid stools.

A reduction of crying hours was also described in infant receiving an hydrolyzed formula. Some probiotics were reported with potential benefit on the gut comfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant Nutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test formula 1

Hydrolyzed formula with probiotics

Group Type EXPERIMENTAL

test formula 1

Intervention Type DIETARY_SUPPLEMENT

hydrolyzed formula with probiotics

test formula 2

acidified hydrolyzed formula.

Group Type ACTIVE_COMPARATOR

test formula 2

Intervention Type DIETARY_SUPPLEMENT

acidified hydrolyzed formula

Test formula 3

hydrolyzed formula without probiotics

Group Type ACTIVE_COMPARATOR

test formula 3

Intervention Type DIETARY_SUPPLEMENT

hydrolyzed formula without probiotics

reference product

standard infant formula

Group Type ACTIVE_COMPARATOR

reference formula

Intervention Type DIETARY_SUPPLEMENT

standard infant formula

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

test formula 1

hydrolyzed formula with probiotics

Intervention Type DIETARY_SUPPLEMENT

test formula 2

acidified hydrolyzed formula

Intervention Type DIETARY_SUPPLEMENT

test formula 3

hydrolyzed formula without probiotics

Intervention Type DIETARY_SUPPLEMENT

reference formula

standard infant formula

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

for 0-6 months as per standard requirement suitable for 0-6 months as per standard requirement suitable for 0-6 months of age as per standard requirement suitable for 0-6 months of age as per standard requirement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy infants, 0-1 month old at point of enrollment
* Birth weight \< 2500g and \> 4500g
* Gestational age \< 37 weeks and \> 42 weeks
* Infants who cannot be breastfed because of the maternal status
* Willing to exclusively consume the assigned study formula with whey protein
* Are likely to be compliant
* Mother/caregiver demonstrates an understanding of the given information and ability to record the requested data

Exclusion Criteria

* Congenital illness or malformation
* Significant pre-natal and/or post-natal disease
* Receiving systemic antibiotic treatment at time of enrolment
* Infant with symptoms of allergy to cow's milk
* Infant's family cannot be expected to comply with treatment (feeding regimen)
* Subjects who cannot be expected to comply with treatment
* Currently participating or having participated in another clinical trial during the last month
Minimum Eligible Age

11 Days

Maximum Eligible Age

30 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chulalongkorn University

OTHER

Sponsor Role collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

A/Prof. Boosba Vivatvakin, MD

Role: PRINCIPAL_INVESTIGATOR

Pediatric Gastroenterology Unit,Faculty of Medicine, Chulalongkorn University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chulalongkorn University

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07.06 INF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.